Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Знаете ли вы? Кликните два раза на слово, чтобы найти его в TermGallery.
Значения термина pharmacokinetic model на английском
Значения для термина "pharmacokinetic model" отсутствуют.
Использование термина pharmacokinetic model на английском
1
The pharmacokineticmodel favours once per day dosing with adjustment for weight.
2
The pharmacokinetics could be described by an open 2-compartment pharmacokineticmodel.
3
Cetuximab concentrations were described using a 2-compartment population pharmacokineticmodel.
4
A pharmacokineticmodel and a BE were developed using an iterative two stage Bayesian approach.
5
Data analysis was performed with a population pharmacokineticmodel with a description of autoinduction of ifosfamide.
6
A population pharmacokineticmodel was developed to describe nelfinavir-M8 concentration time-courses and to estimate interpatient variability.
7
The platform supports pharmacokineticmodel-informed dosing guidance and has functionality to incorporate real-time drug concentration information.
8
A population pharmacokineticmodel was developed using non linear mixed effects modelling techniques, utilizing the software NONMEM.
9
None of the tested covariates was found to be correlated with any of the pharmacokineticmodel parameters.
10
Anti-factor Xa levels were obtained, and a published population pharmacokineticmodel for fondaparinux was fit to the data.
11
The MRI data were acquired with a turbo fast low-angle shot sequence and analyzed using a pharmacokineticmodel.
12
In the pharmacokineticmodel, weight and total bilirubin level were found to be significant predictors of tigecycline clearance.
13
The resultant data provided the framework to develop a hybrid physiologically based pharmacokineticmodel for temozolomide in brain.
14
A previously described population pharmacokineticmodel was used to calculate the maximum a posteriori Bayesian estimates for 187 patients.
15
For the Bayesian approach a three-compartment population pharmacokineticmodel was developed; optimal time-points were selected using the D-optimality algorithm.
16
Objectives: To develop a population pharmacokineticmodel suitable for Bayesian estimation of individual AUC in stable renal transplant patients.